Åsa Grauman

Åsa Grauman

Åsa Grauman

Postdoc

Åsa Grauman studies cancer patients' (acute myological leukemia) preferences and perspectives on individualized treatment using algorithms. The research is part of the multidisciplinary VR project MEET-AML, whose goal is to be able to tailor treatment for individual patients using an algorithm that identifies vulnerabilities in leukemia cells' metabolism using -omics data. The project also includes developing ways to integrate patients' preferences, what they want and their own balance between risk and benefit, in the individualized treatment. In her research, she uses preference studies where both qualitative and quantitative methods are included, to understand how people balance their interests and values.

Åsa Grauman has a master's degree in public health science and has a doctorate in medical science from Uppsala University. Her PhD project was about how people perceive their risk of suffering from heart disease, how people are affected by cardiovascular risk information and their preferences of how risk information should be conveyed. 

E-mail: asa.grauman@crb.uu.se
Phone: +46 18 471 62 44

Recently in media

Recent publications

Informing about cardiovascular risk

Any health care interventions should be made after careful consideration of the benefits and risks for the individual. But experts and the general public sometimes have different views on what the benefit actually is. Understanding how the public perceives risk is important for designing the information correctly: to build on the individual's pre-understanding, to bridge knowledge gaps, and to correct inaccuracies. From a societal perspective, it is also important to ensure that health care efforts are equal. By examining which groups benefit from the efforts, they can be directed towards particularly vulnerable groups and individuals.

This policy brief contains Åsa Grauman's recommendations for how best to inform the public about the risk of cardiovascular disease.

Cardiovascular risk (in Swedish)

Last modified: 2022-03-22